According to OPKO Health 's latest financial reports the company's current EPS (TTM) is -$0.27. In 2022 the company made an earnings per share (EPS) of -$0.44 a decrease over its 2021 EPS that were of -$0.05000.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.27 | -38.64% |
2022 | -$0.44 | 780% |
2021 | -$0.05000 | -200% |
2020 | $0.05000 | -109.43% |
2019 | -$0.53 | 96.3% |
2018 | -$0.27 | -49.06% |
2017 | -$0.53 | 1225% |
2016 | -$0.04000 | -54.06% |
2015 | -$0.08706 | -78.23% |
2014 | -$0.40 | 25% |
2013 | -$0.32 | 190.91% |
2012 | -$0.11 | |
2011 | N/A | -100% |
2010 | -$0.08000 | -50% |
2009 | -$0.16 | -23.81% |
2008 | -$0.21 | -94.47% |
2007 | -$3.80 | 8707.1% |
2006 | -$0.04315 | 43.82% |
2005 | -$0.03000 | -75% |
2004 | -$0.12 | -68.42% |
2003 | -$0.38 | -42.42% |
2002 | -$0.66 | 15.79% |
2001 | -$0.57 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $14.09 | -5,316.78% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $2.97 | -1,200.81% | ๐บ๐ธ USA |
Regeneron Pharmaceuticals REGN | $37.36 | -13,937.04% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $3.97 | -1,570.37% | ๐บ๐ธ USA |
LabCorp LH | $7.52 | -2,885.19% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | -$4.11 | 1,422.22% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | -$2.00 | 640.74% | ๐ฎ๐ฑ Israel |
Ardelyx ARDX | -$0.12 | -55.56% | ๐บ๐ธ USA |